Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease

Multicentric Castleman’s disease (MCD) is a rare, widespread lymphoproliferative disorder and a life-threatening disease involving hyperactivity of the immune system, excessive proinflammatory cytokine release, immune cell proliferation, and organ system dysfunction. Interleukin-6 (IL-6) is a cytoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitenga, Jenna, Aird, Gregory, Ahmed, Aabra, Silberstein, Peter T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769562/
https://www.ncbi.nlm.nih.gov/pubmed/29391839
http://dx.doi.org/10.2147/PROM.S140011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769562/
https://www.ncbi.nlm.nih.gov/pubmed/29391839
http://dx.doi.org/10.2147/PROM.S140011

Ejemplares similares